Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Recombinant Human Albumin: Applications as a Biophamaceutical Excipient

In addition to batc-to-batch consistency, the use of recombinanthuman albumin in biopharmaceutical formulation provides many of the recognised benefits of using human serum albumin as an excipient, whils avoiding the risks of rasmitting viral the prio contaminants.

David Mead, Dermot Pearson and Maree Devine at Novozymes Delta Ltd (April 2007)

    View full article    |    Back to Bioprocessing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |